Reaffirming the Compliance Commitment Across All Affiliates

Jeil Pharma Holdings reaffirmed its commitment to fair trade compliance together with all of its affiliates.


On September 29, Jeil Pharma Holdings announced that it had held the "2026 Jeil Fair Trade Compliance Day" event at its headquarters in Seocho-gu, Seoul, with participation from all affiliates, including Jeil Pharmaceutical and Jeil Health Science.


Jeil Pharma Holdings held the '2026 Jeil Fair Trade Compliance Day' event at its headquarters in Seocho-gu, Seoul, with participation from all affiliates including Jeil Pharmaceutical and Jeil Health Science. Jeil Pharma Holdings

Jeil Pharma Holdings held the '2026 Jeil Fair Trade Compliance Day' event at its headquarters in Seocho-gu, Seoul, with participation from all affiliates including Jeil Pharmaceutical and Jeil Health Science. Jeil Pharma Holdings

View original image

This event was organized to review the fair trade compliance activities and achievements of the past year since the "CP Reinforcement Proclamation Ceremony" held last year, as well as to reaffirm the commitment of all affiliates to legal compliance and ethical management.


Jeil Pharma Holdings shared the successful outcomes of transitioning to the anti-bribery management system standard "ISO 37001:2025" and completing the follow-up audit for the compliance management system "ISO 37301." The company plans to continue advancing its compliance framework, which has been operated around the Fair Trade Compliance Program (CP).


Lee Juhyun, Head of the Compliance Management Division at Jeil Pharma Holdings, shared the key compliance requirements related to fair trade and the importance of ethical management required in the pharmaceutical industry. Subsequently, all executives and employees participated in the compliance pledge, strengthening their resolve to establish a fair and transparent business order and adhere to relevant laws and regulations.



Lee stated, "We will continue to advance our compliance framework with the Fair Trade Compliance Program at its core, embed a culture of transparency and responsibility, and evolve into a trusted pharmaceutical company."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing